# FDA Inspection 1208255 - Procter & Gamble Distributing LLC - May 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/procter-gamble-distributing-llc/03603b67-c7dc-4fe0-9f90-5950c80e589e
Source feed: FDA_Inspections

> FDA Inspection 1208255 for Procter & Gamble Distributing LLC on May 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208255
- Company Name: Procter & Gamble Distributing LLC
- Inspection Date: 2023-05-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310490 - 2026-03-31](https://www.keypedia.com/records/fda_inspections/procter-gamble-distributing-llc/9c488c4a-0ac7-4bed-bff5-a5b254eb04eb)
- [FDA Inspection 1159059 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/procter-gamble-distributing-llc/95884907-0ed7-49db-9312-31e84cae2079)
- [FDA Inspection 1159059 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/procter-gamble-distributing-llc/11decf34-5c7c-4722-ba80-b70222a637cb)

Company: https://www.keypedia.com/companies/procter-gamble-distributing-llc/67a40bc0-5f84-4848-bb9a-243d24ad7ae4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c